Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma (Q64727454)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma |
clinical trial |
Statements
A Phase I/II Trial of Anti-CD80 Monoclonal Antibody (IDEC-114) Therapy for Patients With Relapsed or Refractory Follicular Lymphoma (English)
0 references
January 2002
0 references
September 2002
0 references
42
0 references
18 year
0 references